公开(公告)号：US20180140622A1

公开(公告)日：2018-05-24

申请号：US15874604

申请日：2018-01-18

Applicant: ABBOTT LABORATORIES

Inventor： RACHAEL BUCK ,  GERALYN O. DUSKA-MCEWEN ,  JOSEPH P. SCHALLER

IPC: A61K31/702 ,  A23L33/00 ,  A23L33/12 ,  A61K31/7016 ,  A61K31/202 ,  A61K45/06

CPC classification number: A61K31/702 ,  A23L33/12 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/3202 ,  A23V2200/324 ,  A23V2250/1882 ,  A23V2250/28 ,  A61K31/202 ,  A61K31/7016 ,  A61K45/06 ,  A61K2300/00

Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US20160296544A1

公开(公告)日：2016-10-13

申请号：US15037743

申请日：2014-11-18

Applicant: ABBOTT LABORATORIES

Inventor： RACHAEL BUCK ,  STEVEN DAVIS ,  PAUL FORSYTHE

IPC: A61K31/702 ,  A61K45/06

CPC classification number: A61K31/702 ,  A23L5/00 ,  A23L21/00 ,  A23L29/04 ,  A23L29/045 ,  A23L29/30 ,  A23L33/10 ,  A23L33/115 ,  A23L33/125 ,  A23L33/21 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A23V2250/00 ,  A61K31/445 ,  A61K31/4545 ,  A61K31/495 ,  A61K31/7016 ,  A61K45/06 ,  A61K2300/00 ,  A23V2250/18 ,  A23V2250/28 ,  A23V2250/50 ,  A23V2250/54 ,  A23V2250/60 ,  A23V2200/304

Abstract: A method for preventing or mitigating an acute allergic response in a subject is disclosed. The method includes a step of administering a nutritional composition to the subject. The nutritional composition includes at least one of an acidic or a neutral HMO, but does not include an N-acetyl-lactosamine.

Abstract translation: 公开了一种预防或减轻受试者急性过敏反应的方法。 该方法包括向受试者施用营养组合物的步骤。 营养组合物包括酸性或中性HMO中的至少一种，但不包括N-乙酰基 - 乳糖胺。

公开(公告)号：US20230255991A1

公开(公告)日：2023-08-17

申请号：US18306662

申请日：2023-04-25

Applicant: ABBOTT LABORATORIES

Inventor： RACHAEL BUCK ,  GERALYN O. DUSKA-MCEWEN ,  JOSEPH P. SCHALLER

IPC: A61K31/702 ,  A23L33/00 ,  A23L33/12 ,  A61K31/202 ,  A61K31/7016 ,  A61K45/06

CPC classification number: A61K31/702 ,  A23L33/40 ,  A23L33/12 ,  A61K31/202 ,  A61K31/7016 ,  A61K45/06 ,  A23V2200/3202 ,  A23V2200/324 ,  A23V2250/1882 ,  A23V2250/28 ,  A23V2002/00 ,  A61K2300/00

Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US20230149542A1

公开(公告)日：2023-05-18

申请号：US17917381

申请日：2021-04-06

Applicant: ABBOTT LABORATORIES

Inventor： RACHAEL BUCK ,  MICHAEL FARROW

IPC: A61K39/395 ,  A61K47/12 ,  A61K47/10 ,  A61P29/00 ,  A61P11/00 ,  A61P31/12 ,  A23L33/00 ,  A23L33/12 ,  A23L33/125 ,  A23L33/19 ,  A23L33/155

CPC classification number: A61K39/395 ,  A61K47/12 ,  A61K47/10 ,  A61P29/00 ,  A61P11/00 ,  A61P31/12 ,  A23L33/40 ,  A23L33/12 ,  A23L33/125 ,  A23L33/19 ,  A23L33/155

Abstract: Disclosed are compositions, including nutritional compositions, for reducing illness/infection related symptoms. In particular, administration of the inventive compositions helps to reduce symptoms such as those selected from impaired cognition, fever, anhedonia, loss of appetite, hyperalgesia, and sleep disturbances, lethargy, chills, irritability, and skin hypersensitivity to touch that often result from respiratory virus-induced inflammation.

公开(公告)号：US20210401862A1

公开(公告)日：2021-12-30

申请号：US17473298

申请日：2021-09-13

Applicant: ABBOTT LABORATORIES

Inventor： ENRIQUE VAZQUEZ HERNANDEZ ,  RICARDO RUEDA CABRERA ,  RACHAEL BUCK ,  MARIA RAMIREZ GONZALEZ

IPC: A61K31/702 ,  A61K9/00 ,  A23L33/21 ,  A23L33/00

Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.

公开(公告)号：US20190381077A1

公开(公告)日：2019-12-19

申请号：US16557461

申请日：2019-08-30

Applicant: ABBOTT LABORATORIES

Inventor： ENRIQUE VAZQUEZ HERNANDEZ ,  RICARDO RUEDA CABRERA ,  RACHAEL BUCK ,  MARIA RAMIREZ GONZALEZ

IPC: A61K31/702 ,  A61K9/00 ,  A23L33/21 ,  A23L33/00

Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.

公开(公告)号：US20180133235A1

公开(公告)日：2018-05-17

申请号：US15866322

申请日：2018-01-09

Applicant: ABBOTT LABORATORIES

Inventor： RACHAEL BUCK ,  GERALYN O. DUSKA-MCEWEN ,  JOSEPH P. SCHALLER

IPC: A61K31/702 ,  A23L33/00 ,  A23L33/12 ,  A61K31/7016 ,  A61K31/202 ,  A61K45/06

CPC classification number: A61K31/702 ,  A23L33/12 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/3202 ,  A23V2200/324 ,  A23V2250/1882 ,  A23V2250/28 ,  A61K31/202 ,  A61K31/7016 ,  A61K45/06 ,  A61K2300/00

Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

公开(公告)号：US20140256674A1

公开(公告)日：2014-09-11

申请号：US14195938

申请日：2014-03-04

Applicant: Abbott Laboratories

Inventor： RACHAEL BUCK ,  GERALYN O. DUSKA-MCEWEN ,  JOSEPH P. SCHALLER

IPC: A61K31/702 ,  A61K45/06 ,  A23L1/29 ,  A61K31/202

CPC classification number: A61K31/702 ,  A23L33/12 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/3202 ,  A23V2200/324 ,  A23V2250/1882 ,  A23V2250/28 ,  A61K31/202 ,  A61K31/7016 ,  A61K45/06 ,  A61K2300/00

Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

Abstract translation: 公开了营养组合物，其包括可以与早产儿，足月婴儿，幼儿和儿童一起施用的长链多不饱和脂肪酸和/或类胡萝卜素的人乳低聚糖，以减少炎症和炎性疾病的发生。